Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
9.38
-0.05 (-0.53%)
Sep 2, 2026, 12:01 PM EDT - Market open
Immatics Revenue
Immatics had revenue of 9.14M EUR in the quarter ending June 30, 2026, with 93.03% growth. This brings the company's revenue in the last twelve months to 41.70M, down -67.95% year-over-year. In the year 2025, Immatics had annual revenue of 48.27M, down -69.03%.
Revenue (ttm)
41.70M EUR
Revenue Growth
-67.95%
P/S Ratio
27.01
Revenue / Employee
59,239 EUR
Employees
704
Market Cap
1.28B USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 48.27M | -107.57M | -69.03% |
| Dec 31, 2024 | 155.84M | 101.84M | 188.60% |
| Dec 31, 2023 | 54.00M | -118.83M | -68.76% |
| Dec 31, 2022 | 172.83M | 138.07M | 397.17% |
| Dec 31, 2021 | 34.76M | 3.51M | 11.23% |
| Dec 31, 2020 | 31.25M | 12.80M | 69.40% |
| Dec 31, 2019 | 18.45M | 14.68M | 389.36% |
| Dec 31, 2018 | 3.77M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
IMTX News
- 7 days ago - Immatics price target lowered to $17 from $18 at Jefferies - TheFly
- 8 days ago - Immatics announces $150M offering of common stock priced at $8.69 per share - TheFly
- 8 days ago - Immatics Announces $150 Million Underwritten Offering - GlobeNewsWire
- 14 days ago - Immatics Earnings release: Q2 2026 - Filings
- 15 days ago - Immatics reports Q2 EPS (46c), consensus (48c) - TheFly
- 15 days ago - Immatics Announces Second Quarter 2026 Financial Results and Business Update - GlobeNewsWire
- 6 weeks ago - Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026 - GlobeNewsWire
- 3 months ago - Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting - GlobeNewsWire